Copper Bisglycinate

Copper Bisglycinate Dosage: A Complete Guide

This article is the long-form companion to the short Q&A on copper bisglycinate dosing. It covers the RDA, the upper limit, typical supplement doses, contextual factors that change the right dose, and what the evidence actually supports. If you want the one-sentence answer, the short Q&A version is the place to start. This is for readers who want the full picture.

The three numbers that anchor any copper dose

Every copper dosing decision sits between three reference points: the recommended dietary allowance (RDA), the tolerable upper intake level (UL), and typical dietary intake. All three were established or are reported by the Institute of Medicine and the NIH Office of Dietary Supplements, and they have not changed materially in the past two decades.

The RDA: 900 mcg per day

The recommended dietary allowance for copper in adults aged 19 and over is 900 micrograms (0.9 mg) per day, for both men and women. The figure was set by the Institute of Medicine in 2001 using a combination of indicators including plasma copper, ceruloplasmin concentration, erythrocyte superoxide dismutase activity, and platelet copper concentration in human depletion-repletion studies. Pregnant adults need 1,000 mcg/day; lactating adults need 1,300 mcg/day.

The UL: 10,000 mcg (10 mg) per day

The tolerable upper intake level for adults is 10 mg per day. This is the maximum daily intake the IOM judged unlikely to cause adverse effects in almost all adults. The UL is based on protection against hepatic injury as the critical adverse effect at chronically excessive intake.

Typical dietary intake: 1,100–1,400 mcg/day

U.S. dietary surveys consistently show that most adults already exceed the RDA from food alone. Mean intakes are approximately 1,400 mcg/day for men and 1,100 mcg/day for women, based on NHANES data referenced by the NIH ODS. Food-rich sources include organ meats (especially liver), shellfish (oysters in particular), nuts, seeds, dark chocolate, whole grains, and beans.

Typical supplement doses

Commercial copper bisglycinate supplements are usually dosed in one of three ranges:

Dose per capsule Context
1 mg Lower end. Reasonable if your dietary copper is adequate or if you want a conservative addition.
2 mg The most common dose. Used by Thorne and most major brands. Provides approximately 2.2× the RDA in a single capsule.
3 mg Higher end. Found in products from NutraBio and others. Reasonable for short-term repletion or when zinc co-supplementation is high.
5+ mg Less common. Sometimes used clinically for documented deficiency under supervision. Approaches the upper limit when combined with dietary intake.

For an adult with no specific deficiency context, a 2 mg/day dose combined with typical U.S. dietary intake of ~1,200 mcg/day yields a total daily copper intake of approximately 3.2 mg — well below the 10 mg upper limit and within a range that has been used in many long-term studies without adverse effects.

Factors that change the right dose

Zinc supplementation

If you take zinc above the RDA (8–11 mg/day for adults), copper supplementation deserves consideration. A commonly used guideline is a zinc-to-copper ratio of approximately 10:1 to 15:1. At 30 mg zinc, this puts copper at 2–3 mg/day.

Bariatric surgery

People who have had bariatric surgery — particularly Roux-en-Y gastric bypass — are at elevated risk for copper deficiency due to reduced absorption capacity in the duodenum. Bariatric guidelines from major surgical and nutrition societies typically recommend a copper-containing multivitamin and sometimes additional copper supplementation. Individual doses should be set with a bariatric dietitian or physician.

Restrictive diets

If your diet excludes organ meats, shellfish, nuts, seeds, and chocolate, your dietary copper intake may fall below the RDA. A 1–2 mg copper bisglycinate supplement is a reasonable hedge.

Diagnosed copper deficiency

If a healthcare provider has documented low serum copper or ceruloplasmin, the repletion dose may be higher (3–8 mg/day) for a defined period, then tapered to a maintenance dose. This is a clinical decision and should be made with the provider who diagnosed the deficiency. Self-administering high doses without monitoring is not advisable.

Wilson disease

People with Wilson disease, an inherited disorder of copper transport, should not take copper supplements. Copper bisglycinate is not appropriate at any dose for this population.

What about “clinical” or “therapeutic” doses?

Some functional medicine protocols use copper doses considerably higher than 2 mg — sometimes 4–8 mg/day for short periods to correct documented deficiency or to address specific copper-related concerns. These doses are not unreasonable when used short-term under monitoring, but they put cumulative intake (supplement plus diet) close to the upper limit. Long-term daily intake near or above the UL is what the UL was designed to prevent.

Frequency

Once daily is fine at typical supplemental doses. There is no clinical reason to split a 2 mg dose into two 1 mg doses. At higher therapeutic doses (4 mg+), some clinicians prefer split dosing, but this is preference, not a well-established requirement.

What about cycling?

Some protocols suggest cycling copper — for example, supplementing for several months, then stopping for several months. There is no strong evidence base supporting copper cycling in healthy adults. The more evidence-based approach is to identify whether you have a reason to supplement (zinc co-supplementation, restrictive diet, documented insufficiency), take an appropriate dose during that period, and reassess if the underlying reason changes.

How to know if your dose is right

For most people, dose adequacy can be assessed clinically — by tracking the symptoms that prompted supplementation (fatigue, anemia, etc.) — and through serum copper and ceruloplasmin testing if needed. Routine copper testing is not recommended for healthy adults without symptoms; the test is most useful in evaluating suspected deficiency, monitoring Wilson disease, or assessing patients with relevant clinical findings.

Sources

Share This Post

More Articles

Table of Contents